# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001178913-23-000670
Filing Date
2023-02-21
Accepted
2023-02-21 06:10:48
Documents
73
Period of Report
2022-12-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | zk2329164.htm iXBRL | 8-K | 146711
2 | EXHIBIT 99.1 | exhibit_99-1.htm iXBRL | EX-99.1 | 876112
8 | GRAPHIC | cmmb_img01.jpg | GRAPHIC | 2815
| Complete submission text file | 0001178913-23-000670.txt |  | 5174888

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL SCHEMA FILE | cmmb-20221231.xsd | EX-101.SCH | 56413
4 | XBRL CALCULATION FILE | cmmb-20221231_cal.xml | EX-101.CAL | 46539
5 | XBRL DEFINITION FILE | cmmb-20221231_def.xml | EX-101.DEF | 128511
6 | XBRL LABEL FILE | cmmb-20221231_lab.xml | EX-101.LAB | 489385
7 | XBRL PRESENTATION FILE | cmmb-20221231_pre.xml | EX-101.PRE | 263879
67 | EXTRACTED XBRL INSTANCE DOCUMENT | zk2329164_htm.xml | XML | 757494

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38807 | Film No.: 23645128
SIC: 2834 Pharmaceutical Preparations